Unichem Laboratories has received ANDA approval for its Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Bystolic (nebivolol) Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg, of Allergan Sales, LLC.
Nebivolol Tablets are indicated for the treatment of hypertension. The product will be commercialized from Unichem’s Ghaziabad Plant.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company.
